Life sciences briefing: Tuesday, Dec. 4, 2007
Featured companies: AgraQuest, BridgeHealth, CardioMems, Collegium Pharmaceutical, Emergin, Entegrion, gDiapers, Precision Therapeutics, PregLem
UPDATED: Expanded items on Entegrion, Collegium, and gDiapers. Added CardioMems item. New items posted on AgraQuest (link), BridgeHealth (link) and Precision Therapeutics (link).
Entegrion draws $4.7M for bleeding control — Entegrion, a Research Triangle Park, N.C., biotech focused on products that stop bleeding, raised $4.7 million in a second funding round, VentureWire reports (subscription req’d). Investors included BD Ventures, Catalysta Partners and unnamed individuals.
Entegrion’s main product… Continue Reading
Nancy Pelosi’s biotech earmarks
(UPDATED: See below.)
House Speaker Nancy Pelosi apparently has a warm place in her heart for two San Francisco life-science companies. Buried inside a story on how the Democrat-led Congress seems almost as enthusiastic as its scandal-ridden Republican predecessor about “earmarks” that direct federal money to projects favored by individual legislators, Bloomberg News notes that two of fifteen earmarks Pelosi inserted in a defense-funding measure steer millions of dollars to Prosetta, a Mission Bay biotech, and Bioquiddity,… Continue Reading